VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $624,054,044 | -10.2% | 23,190,414 | +0.5% | 0.07% | -5.5% |
| Q2 2023 | $695,129,533 | -20.1% | 23,086,335 | -14.2% | 0.07% | -18.0% |
| Q1 2023 | $870,220,434 | +12.9% | 26,900,168 | +0.1% | 0.09% | +2.3% |
| Q4 2022 | $770,484,926 | +62.9% | 26,883,633 | +37.1% | 0.09% | +55.4% |
| Q3 2022 | $473,096,000 | -21.0% | 19,614,247 | -10.3% | 0.06% | -18.8% |
| Q2 2022 | $598,589,000 | -38.4% | 21,862,305 | -13.7% | 0.07% | -27.4% |
| Q1 2022 | $970,990,000 | +51.3% | 25,319,142 | +26.4% | 0.10% | +50.8% |
| Q4 2021 | $641,815,000 | +14.3% | 20,037,933 | +5.1% | 0.06% | +8.6% |
| Q3 2021 | $561,714,000 | -35.9% | 19,060,587 | -26.1% | 0.06% | -36.3% |
| Q2 2021 | $876,419,000 | +3.6% | 25,792,189 | -0.9% | 0.09% | -4.2% |
| Q1 2021 | $846,216,000 | +14.4% | 26,037,429 | +26.8% | 0.10% | 0.0% |
| Q4 2020 | $739,428,000 | -45.2% | 20,528,316 | -40.4% | 0.10% | -48.4% |
| Q3 2020 | $1,348,785,000 | -12.8% | 34,442,947 | -18.3% | 0.18% | -22.0% |
| Q2 2020 | $1,546,107,000 | +114.6% | 42,151,259 | +34.8% | 0.24% | +81.5% |
| Q1 2020 | $720,480,000 | -11.5% | 31,270,819 | +12.4% | 0.13% | +11.1% |
| Q4 2019 | $814,383,000 | +20.1% | 27,813,634 | +9.5% | 0.12% | +17.0% |
| Q3 2019 | $678,290,000 | +24.9% | 25,394,614 | +19.5% | 0.10% | +20.5% |
| Q2 2019 | $543,063,000 | -1.8% | 21,246,588 | -13.9% | 0.08% | -4.6% |
| Q1 2019 | $553,193,000 | -47.4% | 24,674,078 | -50.6% | 0.09% | -53.2% |
| Q4 2018 | $1,052,357,000 | +204.3% | 49,898,401 | +167.2% | 0.19% | +244.4% |
| Q3 2018 | $345,806,000 | -33.3% | 18,672,056 | -19.6% | 0.05% | -37.2% |
| Q2 2018 | $518,358,000 | +100.5% | 23,234,345 | +97.5% | 0.09% | +95.5% |
| Q1 2018 | $258,571,000 | +5.3% | 11,763,925 | +11.4% | 0.04% | +7.3% |
| Q4 2017 | $245,440,000 | +9.3% | 10,561,079 | +8.0% | 0.04% | +13.9% |
| Q3 2017 | $224,508,000 | -32.1% | 9,778,195 | -34.7% | 0.04% | -45.5% |
| Q2 2017 | $330,568,000 | +34.4% | 14,971,337 | +38.8% | 0.07% | +34.7% |
| Q1 2017 | $245,974,000 | +22.2% | 10,783,634 | +12.1% | 0.05% | +14.0% |
| Q4 2016 | $201,309,000 | -35.3% | 9,622,786 | -18.3% | 0.04% | -36.8% |
| Q3 2016 | $311,341,000 | -3.2% | 11,779,835 | +1.5% | 0.07% | -10.5% |
| Q2 2016 | $321,600,000 | – | 11,605,863 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |